Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Phase II Study Evaluating the Efficacy and Toxicity of Weekly Paclitaxel in Locally Advanced or Metastatic Soft Tissue Angiosarcomas That Cannot be Treated by Surgery

NCT00217607 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00217607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Phase II Study Evaluating the Efficacy and Toxicity of Weekly Paclitaxel in Locally Advanced or Metastatic Soft Tissue Angiosarcomas That Cannot be Treated by Surgery
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
January 31, 2012
Enrollment
30 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma